Located in MUSC Health's Ashley River Tower, the Cardiovascular Health Program is dedicated to improving cardiovascular health by offering one-stop access to a full range of preventive cardiology services including cardiovascular disease programs. The cardiovascular disease program brings together comprehensive exams performed by experienced cardiovascular specialists, blood lipids management, hypertension management, nutrition counseling, weight management, exercise prescription, diabetes management and vascular services, as well as early detection and advanced cardiac diagnostic imaging.
You’re never too young — or too old — to begin taking preventive measures. More than 78% of U.S. adults between the ages of 20 and 80 have one or more risk factors for cardiovascular disease. The good news is that prevention works — since 1968, U.S. deaths from heart attack and stroke have been reduced by almost 50% largely by addressing the most serious risk factors.
Despite considerable advances in treatment, cardiovascular disease (CVD) remains the leading cause of death for both men and women in the United States.*
The Seinsheimer Cardiovascular Health Program is made possible by Bev and Wally Seinsheimer, Charleston residents whose generous donation helps cover start-up and operating costs. Bev, a former cardiac nurse, member of MUSC Health's Heart & Vascular Board and founder of the MUSC Women’s Heart Health Symposium, and Wally, who serves on the MUSC Foundation’s board of directors, wanted to establish a legacy cardiovascular disease program to help people avoid catastrophic illness and live longer, healthier, more enjoyable lives.
Men and women of any age who have one or more of the following risk factors:
The Medical University of South Carolina has taken the lead in the effort to promote cardiovascular health and heart disease prevention with the development of a comprehensive multispecialty program designed to give at risk individuals the skills and know-how necessary to lead a heart-healthy lifestyle.
Treatment options at the MUSC Statin Intolerance Clinic include intensive nutrition counseling tailored to the patient’s specific lipid disorder, evidence-based use of supplements for non-prescription lowering of LDL-C (such as phytosterols/stanols), use of cholesterol-absorption inhibitors, alternative statin dosing strategies, and low-dose multi-drug regimens. In addition, the MUSC LDL Apheresis Program offers an alternative for patients with severe elevations of LDL-C and known CVD. Investigational medications are also available by participation in one of the currently enrolling clinical trials (such as mipomersen, an injectable inhibitor of apo-B synthesis).